论文部分内容阅读
目的:评价通心络胶囊治疗急性脑梗死的疗效。方法:收集符合治疗标准的急性脑梗死患者76例,随机分为通心络胶囊加常规治疗组和常规治疗组,连续治疗1个月,采用NIHSS评分和Barthel指数进行评分统计。结果:NIHSS评分通心络治疗组治疗后明显低于治疗前(P<0.05)Barthel指数明显高于治疗前(P<0.05)通心络加常规治疗总有效率高于常规治疗组,差异有统计学意义(P<0.05)。结论:通心络胶囊治疗急性脑梗死疗效可靠,安全性高。
Objective: To evaluate the efficacy of Tongxinluo Capsule in the treatment of acute cerebral infarction. Methods: A total of 76 acute cerebral infarction patients were enrolled in this study. They were randomly divided into Tongxinluo capsule group, conventional treatment group and conventional treatment group. The patients were treated continuously for 1 month. NIHSS score and Barthel index were used for the statistics. Results: The NIHSS score of Tongxinluo group was significantly lower than that before treatment (P <0.05), Barthel index was significantly higher than that before treatment (P0.05), Tongxinluo plus routine treatment was higher than the conventional treatment group, the difference was Statistical significance (P <0.05). Conclusion: Tongxinluo capsule is effective and safe in the treatment of acute cerebral infarction.